| Dr Saqib R Nakadar, DO | |
|
37300 Dequindre Rd Ste 102, Sterling Heights, MI 48310-3595 | |
| (586) 983-4200 | |
| Not Available |
| Full Name | Dr Saqib R Nakadar |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 37300 Dequindre Rd Ste 102, Sterling Heights, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538361530 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 5101015984 (Michigan) | Secondary |
| 207R00000X | Internal Medicine | 5101015984 (Michigan) | Primary |
| Entity Name | Jawad A Shah, Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942402391 PECOS PAC ID: 5799779633 Enrollment ID: O20040413000798 |
News Archive
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
BioCardia, Inc., a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Centers for Medicare and Medicaid Services has approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.
The more an EU national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology.
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
› Verified 1 days ago
| Entity Name | Express Med Urgent Care, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649755125 PECOS PAC ID: 0244570034 Enrollment ID: O20190313002364 |
News Archive
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
BioCardia, Inc., a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Centers for Medicare and Medicaid Services has approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.
The more an EU national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology.
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saqib R Nakadar, DO 3707 Durham Ct, Bloomfield Hills, MI 48302-1224 Ph: (248) 766-4977 | Dr Saqib R Nakadar, DO 37300 Dequindre Rd Ste 102, Sterling Heights, MI 48310-3595 Ph: (586) 983-4200 |
News Archive
Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.
BioCardia, Inc., a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Centers for Medicare and Medicaid Services has approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.
The more an EU national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology.
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
› Verified 1 days ago
Dr. Nagina Aslam, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13801 15 Mile Rd, Sterling Heights, MI 48312 Phone: 586-757-9707 | |
Yousuf A. Siddiqui, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 14500 Hall Road, Sterling Heights, MI 48313 Phone: 586-247-2940 Fax: 586-247-3733 | |
Jayashree Sekaran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 3500 Fifteen Mile Road, Sterling Heights, MI 48310 Phone: 586-977-9936 Fax: 586-268-8158 | |
Dr. Stanley B Wolfe, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 37771 Schoenherr Rd, Suite 101, Sterling Heights, MI 48312 Phone: 586-274-2450 Fax: 586-274-2481 | |
Maria Repolski, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Henry Ford Health System, 14500 Hall Road, Sterling Heights, MI 48313 Phone: 586-247-2940 Fax: 586-247-3733 | |
Dr. Sharon K Geimer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 44344 Dequindre Rd, Suite 480, Sterling Heights, MI 48314 Phone: 586-323-8935 Fax: 586-323-9058 | |
Dr. Amro Reda Sheta, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2405 E Fourteen Mile Rd, Sterling Heights, MI 48310 Phone: 586-264-1800 Fax: 586-264-1155 |